← Open Payments lookup

SHANNON REPKA: Open Payments

NPI 1063634897 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$879 in 37 payments from 13 companies in 2025. Trend: 2023 $1,575 · 2024 $1,126 · 2025 $879

Food & beverage: $879
CompanyPaymentsAmount
Alexion Pharmaceuticals, Inc.5$120
PFIZER INC.4$118
Aimmune Therapeutics, Inc.5$116
ABBVIE INC.3$93
VERTEX PHARMACEUTICALS INCORPORATED4$81
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$79
Ferring Pharmaceuticals Inc.2$66
E.R. Squibb & Sons, L.L.C.2$53
Boehringer Ingelheim Pharmaceuticals, Inc.3$52
CSL Behring2$48

Products named: ULTOMIRIS, VYNDAQEL, VOWST, DALVANCE, JOURNAVX, XIFAXAN, REBYOTA, ELIQUIS.

Industry payments across TX — which companies pay providers there.